Lonza

💡 Every biologic program has its own challenges — and it takes an experienced partner to design a downstream strategy that fits. In our #CDMONotesBlog, Cíntia Carreira, Ph.D., Associate Principal Scientist in Purification Development, shares how bespoke downstream processing strategies can improve yield, maintain quality, and streamline development for complex biologics. With over a decade of experience optimizing purification processes, Cíntia brings an expert perspective on why a one-size-fits-all approach no longer works in modern bioprocessing — and how data-driven customization can make all the difference. 🔗 Read the full article: https://lnkd.in/egzAETvx #CDMONotesBlog #IntegratedBiologics #DownstreamProcessing #Biopharma #CDMO #Lonza #Bioprocessing #DrugDevelopment

This week, Lonza joined industry leaders at the Jefferies Healthcare Conference in London, a key platform for connecting with the global investment community. Our CFO, Philippe Deecke, hosted a fireside chat that explored Lonza’s strategic direction and sparked meaningful dialogue. Engaging with investors at Jefferies is a chance to reinforce transparency, build trust, and gather valuable feedback on market expectations. These conversations help shape our long-term strategy and strengthen relationships that drive sustainable growth. Thank you to everyone who joined us and contributed to these meaningful exchanges. #Lonza #Jefferies2025 #CDMO

🚀 Biologics In Focus – November 2025 Our latest edition is here! This month, we dive into strategies to accelerate biologics programs from early-stage research to commercial readiness, covering smarter CMC planning, integrated manufacturing, and innovative analytical technologies. Highlights include: - Rapid toxicity programs to streamline IND submission - HCP ELISA bridging strategies for smoother tech transfers - Smarter CMC approaches to advance next-generation biologics - Integrated DS/DP manufacturing to mitigate risk and simplify commercial supply - Insights on process intensification driving analytical innovation - Swissmedic approval of the new aseptic filling facility in Stein 🎯 Why read it: Gain practical insights, expert guidance, and access to webinars that help you navigate biologics development with confidence. 📖 Read the full newsletter here. #IntegratedBiologics #BiologicsInFocus #Biotechnology #ThePeoplePoweringBiologics

Design2Optimize™ helps drug developers work not just faster, but smarter. Our new award-winning offering enhances the process development and manufacturing of small molecule APIs, accelerating the path to manufacturing and increasing the likelihood of right-first-time processes. It allows for running in-silico experiments, saving both time and cost, and ensuring that processes are running as efficiently as possible. The platform helps drug developers to build predictive models at speed, even for complex or poorly-understood reactions. By generating a digital twin of each process, the platform enables scenario testing in-situ without the need for further physical experimentation. Design2Optimize™ was recently recognized by Pharma Manufacturing as a winner of its 2025 Pharma Innovation Awards for advancing pharmaceutical manufacturing with new technology. #Lonza #CDMO #DrugDevelopment #Innovation

Ready to power greener pharma synthesis? Join our webinar “Electrons Over Metals: Powering Greener Pharma Synthesis” on Dec 4, 2025 | 4:00–5:00 PM CET. Electrochemistry is transforming synthetic chemistry—delivering sustainable, scalable, and metal-free alternatives to traditional oxidative processes. Our colleagues Simon Wagschal and Dominique Roberge will guide you through real-world applications, from amino acid acetoxylation to fluorinated compounds and antibody drug conjugates, showing how these strategies enable greener pharma solutions. ✅ Practical insights for CMC leads, process chemists, and chemical development teams ✅ Opportunity to submit questions during the session ✅ e-Certificate for live attendees + access to recording 👉 Reserve your spot now: https://ow.ly/PBHL50Xr1vo #Electrochemistry #PharmaInnovation #DrugDevelopment #ProcessChemistry #Lonza

In our One Lonza business, our company values define who we are, how we work together, and how we engage with partners and the wider world. ▶️ Collaboration: We win as a strong, inclusive team ▶️ Accountability: We keep the promises we make ▶️ Excellence: We strive to outperform in everything we do ▶️ Passion: We care deeply about what we do for our customers and their patients ▶️ Integrity: We are responsible for our actions and live up to our standards Our values form the foundations of a unified company culture that guides us in pursuit of our vision to become the pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology and lean manufacturing. In this video, our people from across the organization share what these values mean to them and to our business. #Lonza #CDMO #Values

🔬 Featured Insight from Lonza CDMO Notes Blog As new molecular formats (NMF) continue to diversify the biologics landscape, toolbox approaches to analytical methods are key to accelerating development timelines and ensuring quality. In this article, our experts share how Lonza’s analytical development services help biotech and pharma partners navigate complex modalities — from bispecifics to fusion proteins — with the right balance of speed, robustness and regulatory readiness. 👤 About the author - Jennifer Newman Jennifer Newman, Principal Scientist, Analytical Development at Lonza, brings nearly two decades of experience across biologics R&D and manufacturing. She is supporting analytical strategies for mAbs, Fc bispecific and complex programs. 📖 Read the article: https://lnkd.in/esbEy2NC #Biologics #CDMO #AnalyticalDevelopment #Lonza #IntegratedBiologics #NextGenTherapeutics #CDMONotesBlog

How is Lonza meeting the demands of increasingly complex molecules? We are responding to these needs of our customers and their patients by developing innovative solutions to assist with complex synthesis. We bring three components together, empowered by AI and automation to accelerate the journey toward the clinic and the market. #Lonza #CDMO #DrugDevelopment #Innovation #ArtificialIntelligence

Camille’s journey at Lonza began in 2023 in a cross-functional strategy role, where he worked closely with the R&D team to align their efforts with the needs of our Mammalian customers. That experience laid the foundation for his current position as Head of Strategy and Innovation within the Integrated Biologics R&D team, a natural evolution of his earlier work. Today, Camille leads a diverse group of experts spanning strategy, external innovation, competitive intelligence, communications, and the newly established Strategic Innovation Accelerator. For him, leadership is about offering authentic feedback, delivered with genuine care. As he puts it: “Whether or not you manage people, helping others thrive is part of the job.” His advice? “Work on yourself. I’ve learned that focusing on your strengths is a powerful multiplier of your capabilities. Seizing a true opportunity means embracing change and discomfort, because that’s often where growth hides.” #Lonza #CDMO #CareerGrowth #Opportunities

We're the Gold Sponsor for this year's AAEV 2025 and look forward to see you at our booth (20) and our presentation: Extracellular Vesicles: Accelerating your Path from Benchtop to IND & Beyond 🔹Saturday, November 22 🔹11:50am - 12:10pm Presented by: Mark Langtry, Director, Commercial Development Ilaria Passalacqua, Scientist II #Lonza #AAEV